Compare Iron Mountain Inc (IRM) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iron Mountain Inc vs Medpace Holdings Inc — how do they compare? Iron Mountain Inc trades at $114.8 (market cap $34.46B), while Medpace Holdings Inc trades at $611.57 (market cap $16.82B). The key difference: Iron Mountain Inc is far larger — about 2× Medpace Holdings Inc's market cap, and Iron Mountain Inc pays a 2.99% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iron Mountain Inc for 80 Days and Medpace Holdings Inc for 14 Days on average.
| IRM | MEDP | |
|---|---|---|
Market Cap | $34.46B | $16.82B |
Volume | 1,379,608 | 223,093 |
Sector | Real Estate | Health |
52-Week High | $133.06 | $630.19 |
52-Week Low | $78.86 | $393.42 |
Typical Hold Time | 80 Days | 14 Days |
Enterprise Value | $53.87B | $16.44B |
Dividend Yield | 2.99% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Iron Mountain (IRM) trades at $114.51, down 1.05% on the day, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth from $5.1B in 2022 to $6.9B in 2025, though net margins have compressed from 10.91% to 2.09% over the same period. Recent news highlights expansion in data center capacity and digital partnerships, while analyst consensus remains bullish with a $142.75 price target representing 25% upside.
The outlook balances growth opportunities in digital services against significant financial leverage, with debt-to-assets rising to 79.04% in 2025. While the data center pipeline and cross-selling potential provide catalysts, high valuation multiples and interest expense pressure create headwinds. The stock offers potential for investors comfortable with REIT leverage profiles seeking exposure to digital infrastructure expansion.
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
